{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-05",
    "results": {
      "skip": 0,
      "limit": 5,
      "total": 279
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Parsippany",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA040422"
        ],
        "brand_name": [
          "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"
        ],
        "generic_name": [
          "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"
        ],
        "manufacturer_name": [
          "Teva Pharmaceuticals USA, Inc."
        ],
        "product_ndc": [
          "0555-0775",
          "0555-0971",
          "0555-0972",
          "0555-0776",
          "0555-0777",
          "0555-0973",
          "0555-0974"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "DEXTROAMPHETAMINE SACCHARATE",
          "AMPHETAMINE ASPARTATE MONOHYDRATE",
          "DEXTROAMPHETAMINE SULFATE",
          "AMPHETAMINE SULFATE"
        ],
        "rxcui": [
          "541363",
          "541878",
          "541892",
          "577957",
          "577961",
          "687043",
          "1009145"
        ],
        "spl_id": [
          "88468f3d-7d03-4cee-aabf-3abc8c9b5e38"
        ],
        "spl_set_id": [
          "cffbbb15-d776-41ae-a8a6-687f2c07bfa4"
        ],
        "package_ndc": [
          "0555-0971-02",
          "0555-0775-02",
          "0555-0972-02",
          "0555-0776-02",
          "0555-0777-02",
          "0555-0973-02",
          "0555-0974-02"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "G83415V073",
          "O1ZPV620O4",
          "JJ768O327N",
          "6DPV8NK46S"
        ]
      },
      "product_type": "Drugs",
      "event_id": "85712",
      "recalling_firm": "Teva Pharmaceuticals USA",
      "address_1": "400 Interpace Pkwy",
      "address_2": "N/A",
      "postal_code": "07054-1120",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within the United State and Puerto Rico.",
      "recall_number": "D-1285-2020",
      "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets ( Mixed Amphetamine Salts Product), 5 mg, 100 count bottles, Rx Only, Teva Pharmaceuticals USA, INC. North Wales, PA 19454, NDC 0555-0971-02",
      "product_quantity": "33,280 bottles",
      "reason_for_recall": "Some bottles may contain mixed strengths of the product.",
      "recall_initiation_date": "20200522",
      "center_classification_date": "20200604",
      "termination_date": "20210525",
      "report_date": "20200610",
      "code_info": "Lot #: 42614718, Exp. date 02/2021"
    },
    {
      "status": "Ongoing",
      "city": "Parsippany",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {
        "application_number": [
          "ANDA072695"
        ],
        "brand_name": [
          "NORTREL"
        ],
        "generic_name": [
          "NORETHINDRONE AND ETHINYL ESTRADIOL"
        ],
        "manufacturer_name": [
          "Teva Pharmaceuticals USA, Inc."
        ],
        "product_ndc": [
          "0555-9008",
          "0555-9009",
          "0555-9010"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "rxcui": [
          "310463",
          "312033",
          "748797",
          "749858",
          "749869",
          "749879",
          "751868",
          "751870",
          "751871"
        ],
        "spl_id": [
          "9ac007e4-792d-4122-8daf-456dea28f82f"
        ],
        "spl_set_id": [
          "140c50d6-c931-423a-9aa0-526eae7ab93c"
        ],
        "package_ndc": [
          "0555-9009-80",
          "0555-9009-42",
          "0555-9010-79",
          "0555-9010-58",
          "0555-9008-79",
          "0555-9008-67"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "M0447349",
          "N0000175602",
          "N0000175825",
          "N0000000100"
        ],
        "pharm_class_cs": [
          "Progesterone Congeners [CS]"
        ],
        "pharm_class_epc": [
          "Progestin [EPC]",
          "Estrogen [EPC]"
        ],
        "pharm_class_moa": [
          "Estrogen Receptor Agonists [MoA]"
        ],
        "unii": [
          "T18F433X4S",
          "423D2T571U"
        ]
      },
      "product_type": "Drugs",
      "event_id": "93867",
      "recalling_firm": "Teva Pharmaceuticals USA, Inc",
      "address_1": "400 Interpace Pkwy Bldg A",
      "address_2": "N/A",
      "postal_code": "07054-1120",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "nationwide",
      "recall_number": "D-0321-2024",
      "product_description": "Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons, each carton contains 3 blister cards, each card contains 28 tablets, Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0555-9008-67",
      "product_quantity": "12,916 cartons",
      "reason_for_recall": "Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.",
      "recall_initiation_date": "20240125",
      "center_classification_date": "20240212",
      "report_date": "20240221",
      "code_info": "Lot #: 100042978, Exp 7/31/2024"
    },
    {
      "country": "United States",
      "city": "Parsippany",
      "address_1": "400 Interpace Pkwy",
      "reason_for_recall": "CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.",
      "address_2": "",
      "product_quantity": "2,924,000 tablets",
      "code_info": "Arrow Malta (Teva) Bulk Product Lot #  1169752A, exp. date 01/2020, 1000 tablets/bottle  1169753A, exp. date 01/2020, 90 tablets/bottle    Golden State Medical Finished Product Lot #  GS017387, exp. date 01/2020  GS017651, exp. date 01/2020  GS017479, exp. date 01/2020",
      "center_classification_date": "20190709",
      "distribution_pattern": "Nationwide by 4 major distributors.",
      "state": "NJ",
      "product_description": "LOSARTAN POTASSIUM 50 mg TABLET BULK  90 count bottles and 1000 count bottles, NDC 00591-3746-00",
      "report_date": "20190717",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Teva Pharmaceuticals USA",
      "recall_number": "D-1455-2019",
      "initial_firm_notification": "E-Mail",
      "product_type": "Drugs",
      "event_id": "83050",
      "more_code_info": "",
      "recall_initiation_date": "20190606",
      "postal_code": "07054-1120",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Ongoing"
    },
    {
      "status": "Terminated",
      "city": "Parsippany",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {
        "application_number": [
          "NDA208216"
        ],
        "brand_name": [
          "AZACITIDINE"
        ],
        "generic_name": [
          "AZACITIDINE"
        ],
        "manufacturer_name": [
          "BluePoint Laboratories"
        ],
        "product_ndc": [
          "68001-313"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS",
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "AZACITIDINE"
        ],
        "rxcui": [
          "485246"
        ],
        "spl_id": [
          "36080e4e-a0fe-ba15-e063-6394a90aed5c"
        ],
        "spl_set_id": [
          "5f0f9ee3-a5b1-4a25-a34c-7f38c8433f4a"
        ],
        "package_ndc": [
          "68001-313-56"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0368001313568"
        ],
        "nui": [
          "N0000000233",
          "N0000175595"
        ],
        "pharm_class_moa": [
          "Nucleic Acid Synthesis Inhibitors [MoA]"
        ],
        "pharm_class_epc": [
          "Nucleoside Metabolic Inhibitor [EPC]"
        ],
        "unii": [
          "M801H13NRU"
        ]
      },
      "product_type": "Drugs",
      "event_id": "90594",
      "recalling_firm": "Teva Pharmaceuticals USA Inc",
      "address_1": "400 Interpace Pkwy Bldg A",
      "address_2": "",
      "postal_code": "07054-1120",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Distributed in Ohio",
      "recall_number": "D-1334-2022",
      "product_description": "Azacitidine for Injection 100mg/vial Lyophilized Powder, Rx Only, Mfd. in Romania By: Sindan Pharma SRL For BluePoint Laboratories, NDC 68001-313-56",
      "product_quantity": "4162 cartons",
      "reason_for_recall": "Subpotent Drug - Out of specification (OOS) result obtained during monitoring stability study for Assay. Results below specification.",
      "recall_initiation_date": "20220722",
      "center_classification_date": "20220811",
      "termination_date": "20230412",
      "report_date": "20220817",
      "code_info": "Lot: FE22001A, Exp 01/2024",
      "more_code_info": ""
    },
    {
      "status": "Terminated",
      "city": "Horsham",
      "state": "PA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA076001"
        ],
        "brand_name": [
          "FLUOXETINE"
        ],
        "generic_name": [
          "FLUOXETINE"
        ],
        "manufacturer_name": [
          "Teva Pharmaceuticals USA, Inc."
        ],
        "product_ndc": [
          "50111-647",
          "50111-648"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "FLUOXETINE HYDROCHLORIDE"
        ],
        "rxcui": [
          "310384",
          "310385"
        ],
        "spl_id": [
          "424ed364-e023-472f-b113-673e9342a7f1"
        ],
        "spl_set_id": [
          "06d71a33-5578-4012-b11d-764f45bc1e6a"
        ],
        "package_ndc": [
          "50111-647-01",
          "50111-647-02",
          "50111-647-03",
          "50111-648-01",
          "50111-648-02",
          "50111-648-03",
          "50111-648-44"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "I9W7N6B1KJ"
        ]
      },
      "product_type": "Drugs",
      "event_id": "70976",
      "recalling_firm": "Teva Pharmaceuticals USA",
      "address_1": "425 Privet Rd",
      "address_2": "",
      "postal_code": "19044-1220",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0971-2015",
      "product_description": "Fluoxetine Capsules USP, 20 mg, packaged in a) 500-count bottles (NDC 50111-648-02), and (b) 1000- count bottles (NDC 50111-648-03), Rx only, Manufactured by Pliva Krakow Pharmaceutical Company S.A., Krakow, Poland; Manufactured for Teva Pharmaceuticals USA, Sellersville, PA 18960",
      "product_quantity": "",
      "reason_for_recall": "Chemical Contamination: Product recalled due to an elevated level of a residual solvent impurity in the API that exceeds the Threshold of Toxicological Concern (TTC) calculation for the impurity.",
      "recall_initiation_date": "20150413",
      "center_classification_date": "20150427",
      "termination_date": "20161027",
      "report_date": "20150506",
      "code_info": "Lot #: a) 6A208123, Exp 8/2015; b) 6A208121, Exp  8/2015.",
      "more_code_info": ""
    }
  ]
}